ES527515A0 - Procedimiento para la obtencion de benzofuranonas - Google Patents

Procedimiento para la obtencion de benzofuranonas

Info

Publication number
ES527515A0
ES527515A0 ES527515A ES527515A ES527515A0 ES 527515 A0 ES527515 A0 ES 527515A0 ES 527515 A ES527515 A ES 527515A ES 527515 A ES527515 A ES 527515A ES 527515 A0 ES527515 A0 ES 527515A0
Authority
ES
Spain
Prior art keywords
benzofuranonas
procedure
obtaining
obtaining benzofuranonas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES527515A
Other languages
English (en)
Other versions
ES8608502A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES8608502A1 publication Critical patent/ES8608502A1/es
Publication of ES527515A0 publication Critical patent/ES527515A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
ES527515A 1981-10-28 1983-11-24 Procedimiento para la obtencion de benzofuranonas Expired ES8608502A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH688181 1981-10-28

Publications (2)

Publication Number Publication Date
ES8608502A1 ES8608502A1 (es) 1986-06-16
ES527515A0 true ES527515A0 (es) 1986-06-16

Family

ID=4316522

Family Applications (3)

Application Number Title Priority Date Filing Date
ES516841A Expired ES8406461A1 (es) 1981-10-28 1982-10-26 Procedimiento para la obtencion de benzofuranonas
ES527515A Expired ES8608502A1 (es) 1981-10-28 1983-11-24 Procedimiento para la obtencion de benzofuranonas
ES531103A Granted ES531103A0 (es) 1981-10-28 1984-03-29 Procedimiento para la obtencion de benzofuranonas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES516841A Expired ES8406461A1 (es) 1981-10-28 1982-10-26 Procedimiento para la obtencion de benzofuranonas

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES531103A Granted ES531103A0 (es) 1981-10-28 1984-03-29 Procedimiento para la obtencion de benzofuranonas

Country Status (15)

Country Link
US (1) US4514415A (es)
EP (1) EP0078240A3 (es)
JP (1) JPS5888374A (es)
AU (1) AU8982282A (es)
DD (1) DD206376A5 (es)
DK (1) DK475882A (es)
ES (3) ES8406461A1 (es)
FI (1) FI823639L (es)
GB (1) GB2110664B (es)
GR (1) GR77708B (es)
IL (1) IL67063A0 (es)
NO (1) NO823587L (es)
NZ (1) NZ202298A (es)
PT (1) PT75748B (es)
ZA (1) ZA827846B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2611713B1 (fr) * 1987-02-27 1990-11-30 Adir Nouveaux derives de l'acide (dihydro-2,3 oxo-2 benzofurannyl-3)-2 acetique, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US4849428A (en) * 1987-11-23 1989-07-18 The Procter & Gamble Company Cyclic anti-inflammatory derivatives of di-tert-butylphenol compounds, compositions and use
DE58902111D1 (de) * 1988-03-16 1992-10-01 Ciba Geigy Ag Thioverbindungen.
FR2686880B1 (fr) * 1992-02-04 1994-05-13 Hoechst Ste Francaise Procede de preparation de la chloro-5 3h-benzofuranone-2 et son application a l'obtention de l'acide chloro-5 hydroxy-2 phenylacetique.
ES2138902B1 (es) * 1997-05-19 2000-09-16 Salvat Lab Sa "5-ariltio-6-sulfonamido-3(2h)-benzofuranonas como inhibidores de la cox-2".
CA2294126A1 (en) 1997-06-26 1999-01-07 Douglas Wade Beight Antithrombotic agents
ATE252580T1 (de) 1999-07-30 2003-11-15 Zenyaku Kogyo Kk Azaindolizinon-derivate und agenzien zur verbesserung der kognitiver fähigkeiten,die dieselben als aktive inhaltstoffe enthalten
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
PT1889198E (pt) 2005-04-28 2015-03-06 Proteus Digital Health Inc Sistema fármaco-informático
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
WO2010095940A2 (en) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Glutathione-based drug delivery system
NZ596876A (en) 2009-05-06 2014-01-31 Lab Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
GB201415329D0 (en) 2014-07-21 2014-10-15 Ge Healthcare Bio Sciences Parallel cell processing method and facility

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3424796A (en) * 1965-03-30 1969-01-28 Sandoz Ag Preparation of 4-aminodibenzo(a,d) cycloalken-5-ones
US3615521A (en) * 1968-10-01 1971-10-26 Eastman Kodak Co Photographic compositions and processes-a
DE2160136C3 (de) * 1971-12-03 1975-01-02 International Flavors & Fragrances Inc., New York, N.Y. (V.St.A.) Sonnenschutzmittel
US3862133A (en) * 1973-04-30 1975-01-21 Goodrich Co B F Gamma-lactones of o-hydroxyphenylacetic acids
DE2503223A1 (de) * 1974-02-05 1975-08-07 Sandoz Ag Verfahren zur herstellung neuer carbocyclischer verbindungen
US4013690A (en) * 1974-02-05 1977-03-22 Sandoz Ltd. Organic compounds
JPS5938268B2 (ja) * 1974-03-22 1984-09-14 カンザキセイシ カブシキガイシヤ 新規フタリド化合物の製造法
DK137274B (da) * 1975-03-12 1978-02-13 Sandoz Ag Analogifremgangsmåde til fremstilling af 2,3-dihydrobenzofuranon-2-derivater.
DE2652034A1 (de) * 1976-11-15 1978-05-24 Basf Ag Lichtschutzmittel
CA1113486A (en) * 1977-04-01 1981-12-01 Alfred Halpern Ultra-violet filtration with certain aminosalicylic acid esters

Also Published As

Publication number Publication date
ES516841A0 (es) 1984-08-01
DD206376A5 (de) 1984-01-25
EP0078240A3 (de) 1984-03-28
ES8608502A1 (es) 1986-06-16
ES8506686A1 (es) 1985-07-16
GB2110664B (en) 1985-03-20
PT75748A (de) 1982-11-01
EP0078240A2 (de) 1983-05-04
ES531103A0 (es) 1985-07-16
AU8982282A (en) 1983-05-05
JPS5888374A (ja) 1983-05-26
FI823639A0 (fi) 1982-10-25
DK475882A (da) 1983-04-29
GR77708B (es) 1984-09-25
NO823587L (no) 1983-04-29
GB2110664A (en) 1983-06-22
US4514415A (en) 1985-04-30
FI823639L (fi) 1983-04-29
IL67063A0 (en) 1983-02-23
ZA827846B (en) 1983-08-31
ES8406461A1 (es) 1984-08-01
NZ202298A (en) 1985-11-08
PT75748B (de) 1985-12-03

Similar Documents

Publication Publication Date Title
ES528142A0 (es) Procedimiento para la obtencion de compuestos de hexapiranosa
ES500791A0 (es) Procedimiento para la obtencion de polieterpolioles
ES515084A0 (es) Procedimiento para la obtencion de 2-arilimidazopiridinas.
ES533538A0 (es) Procedimiento para la obtencion de tetrahidropiridazinonas
ES502573A0 (es) Procedimiento para la obtencion de imidazoazoalquenamidas
ES505910A0 (es) Procedimiento para la obtencion de metilformiato
ES531103A0 (es) Procedimiento para la obtencion de benzofuranonas
MX7339E (es) Procedimiento mejorado para la obtencion de n- acrilamidas
MX156530A (es) Procedimiento mejorado para la obtencion de carboximetilcelulosa
ES515445A0 (es) Procedimiento para la obtencion de amino-organoaminosilosanos.
ES526042A0 (es) Procedimiento para la obtencion de azolilbutanoles
ES526892A0 (es) Procedimiento para la obtencion de benzofuranonas
ES518617A0 (es) Procedimiento para la obtencion de p-tercioctil-fenol.
ES533988A0 (es) Procedimiento para la obtencion de mercaptocarboxilamidas
ES525257A0 (es) Procedimiento para la obtencion de poliamido-imidas
ES522323A0 (es) Procedimiento para la obtencion de 2-halogenopropionatos sustituidos.
ES498573A0 (es) Procedimiento para la obtencion de nuevos tioles
ES537285A0 (es) Procedimiento para la obtencion de derivados de fenol
ES507522A0 (es) Procedimiento para la obtencion de 1-fenil-2-triazolil-1-penten-3--oles
ES510955A0 (es) Procedimiento para la obtencion de metilomelaminas monomeras
ES537129A0 (es) Procedimiento para la obtencion de iodacetamidas
ES538169A0 (es) Procedimiento para la obtencion de carboximetilesteres
ES511969A0 (es) Procedimiento para la obtencion de 2-aminoetanoles sustituidos.
ES509576A0 (es) Procedimiento para la obtencion de oximcarbamatos n-sulfenilados.
AR231445A1 (es) Procedimiento para obtener 3-2-piperidil-4-1-alquiletil-indoles